Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

CoreAge Rx vs Synergy Rx

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade A · #1

CoreAge Rx

Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.

Visit CoreAge Rx
VS
Grade C · #31

Synergy Rx

People who want a genuine brand-name route and maximum clinician access, and will accept getting a quote by enquiry.

Visit Synergy Rx

The verdict

Winner · CoreAge RxGrade A vs C

CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 71. Best value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Synergy Rx still earns a CPeople who want a genuine brand-name route and maximum clinician access, and will accept getting a quote by enquiry.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

93
70

Price Transparency

97
52

Nationwide Access

98
62

Formulation Options

84
84

Clinical Oversight

90
90

Contract Flexibility

95
68

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecCoreAge RxSynergy Rx
Cost-Efficiency Index94/10071/100
Semaglutide / mo$149/moFrom $199/mo
Tirzepatide / mo$349/moFrom $349/mo
Semaglutide / yr (modeled)$1,788$2,388
Tirzepatide / yr (modeled)$4,188$4,188
CoverageAll 50 statesNot disclosed
Oral / sublingualNoNo
Brand-name accessCompounded onlyYes
Rank on the board#1#31

CoreAge Rx

94/100

Where the value is

  • Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
  • Both compounded semaglutide and tirzepatide on one account at published prices
  • Available in all 50 states — no coverage gamble

The tradeoffs

  • Not the rock-bottom sticker price — cheaper teaser tiers exist (Direct GLP lists $65, Ondra $93 on semaglutide)
  • No FDA-approved brand-name option (compounded only)
Visit CoreAge Rx

Full CoreAge Rx review →

Synergy Rx

71/100

Where the value is

  • Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate, not compounded only
  • Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
  • A $100 welcome credit applied at checkout, and FSA/HSA eligible

The tradeoffs

  • Publishes no GLP-1 price anywhere on its own site, so total cost cannot be modelled before an enquiry
  • At $349/mo tirzepatide sits roughly $100 above the compounded median we track
Visit Synergy Rx

Full Synergy Rx review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons